abstract |
The present invention relates to the use of piperidin-4-ylamine which is useful for the treatment of diseases associated with the activity of JAK1, including the activity of Janus kinase 1 (JAK1), including, for example, inflammatory disorders, autoimmune disorders, A thiazolidine derivative, and compositions and methods of use. |